SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-May-22 6:20 PM View: | Revance Therapeutics, Inc. (RVNC) | 04-May-22 | Grant | 6,059 | -- | -- | 26% 23.66K to 29.72K | |
08-Jul-21 4:21 PM View: | Tectonic Therapeutic, Inc. (TECX) | 07-Jul-21 | Market Purchase | 4,800 | $8.35 | $40,080.00 | 100% 0 to 4.8K | < 1% |
07-May-21 7:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-May-21 | Grant | 4,013 | -- | -- | 20% 19.65K to 23.66K | |
15-May-20 6:42 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-May-20 | Grant | 6,000 | -- | -- | 44% 13.65K to 19.65K | |
10-May-19 9:11 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-May-19 | Grant | 4,500 | -- | -- | 49% 9.15K to 13.65K | |
11-May-18 8:31 PM View: | Revance Therapeutics, Inc. (RVNC) | 10-May-18 | Grant | 3,000 | -- | -- | 49% 6.15K to 9.15K | |
16-Mar-18 8:05 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Mar-18 | Market Purchase | 3,150 | $31.24 | $98,392.50 | 105% 3.0K to 6.15K | (12%) |
12-May-17 7:50 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-May-17 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K |